Does tranexamic acid stabilised fibrin support the osteogenic differentiation of human periosteum derived cells?

European Cells and Materials

Volumn 21, Issue , 2011, Pages 272-285

  Demol, J ^a   Eyckmans, J ^a   Roberts, S J ^a   Luyten, F P ^a   van Oosterwyck, H ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Bone; Cell material interactions; Fibrin; Human periosteum derived cells; Hydrogels; In vitro; Tissue engineering

Indexed keywords

AGGRECAN; ALKALINE PHOSPHATASE BONE ISOENZYME; CALCIUM; COLLAGEN TYPE 1; COLLAGEN TYPE 2; DNA; FIBRIN GLUE; OSTEOCALCIN; PLASTIC; TRANEXAMIC ACID; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9; ALIZARIN; ANTHRAQUINONE DERIVATIVE; BIOLOGICAL MARKER; FIBRIN;

ADULT; ARTICLE; BONE MINERALIZATION; CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHILD; CONTROLLED STUDY; DNA CONTENT; FEMALE; FIBRINOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERMETHOD COMPARISON; MALE; MONOLAYER CULTURE; OSTEOBLAST; PERIOSTEUM; PRESCHOOL CHILD; PROTEIN EXPRESSION; SCHOOL CHILD; UPREGULATION; BONE DEVELOPMENT; CELL COUNT; CELL SHAPE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING;

ADULT; ANTHRAQUINONES; BIOLOGICAL MARKERS; CALCIUM; CELL COUNT; CELL DIFFERENTIATION; CELL SHAPE; CELL SURVIVAL; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; DNA; FEMALE; FIBRIN; GENE EXPRESSION REGULATION; HUMANS; MALE; OSTEOGENESIS; PERIOSTEUM; PROTEIN STABILITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAINING AND LABELING; TRANEXAMIC ACID; YOUNG ADULT;

EID: 79960993951     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/eCM.v021a21     Document Type: Article

References (52)

1. Abiraman S, Varma HK, Umashankar PR, John A (2002) Fibrin glue as an osteoinductive protein in a mouse model. Biomaterials 23: 3023-3031.
2. Arnsdorf EJ, Jones LM, Carter DR, Jacobs CR (2009) The periosteum as a cellular source for functional tissue engineering. Tissue Eng Part A 15: 2637-2642.
3. Bensaid W, Triffitt JT, Blanchat C, Oudina K, Sedel L, Petite H (2003) A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 24: 2497-2502.
4. Blomback B (1996) Fibrinogen and fibrin-proteins with complex roles in hemostasis and thrombosis. Thromb Res 83: 1-75.
5. Brittberg M, Jansson ES, Lindahl A, Peterson L (1997) Influence of fibrin sealant (Tisseel) on osteochondral defect repair in the rabbit knee. Biomaterials 18: 235-242.
6. Busuttil RW (2003) A comparison of antifibrinolytic agents used in hemostatic fibrin sealants. J Am Coll Surg 197: 1021-1028.
7. Carmagnola D, Berglundh T, Araujo M, Albrektsson T, Lindhe J (2000) Bone healing around implants placed in a jaw defect augmented with Bio-Oss. An experimental study in dogs. J Clin Periodontol 27: 799-805.
8. Catelas I, Sese N, Wu BM, Dunn JC, Helgerson S, Tawil B (2006) Human mesenchymal stem cell proliferation and osteogenic differentiation in fibrin gels in vitro. Tissue Eng 12: 2385-2396.
9. Chen WL, Likhitpanichkul M, Ho A, Simmons CA (2010) Integration of statistical modeling and high-content microscopy to systematically investigate cell-substrate interactions. Biomaterials 31: 2489-2497.
10. Cholewinski E, Dietrich M, Flanagan TC, Schmitz-Rode T, Jockenhoevel S (2009) Tranexamic acid - an Alternative to Aprotinin in Fibrin-Based Cardiovascular Tissue Engineering. Tissue Eng Part A 15: 3645-3653.
11. Cox S, Cole M, Tawil B (2004) Behavior of human dermal fibroblasts in three-dimensional fibrin clots: dependence on fibrinogen and thrombin concentration. Tissue Eng 10: 942-954.
12. Cunin G, Boissonnet H, Petite H, Blanchat C, Guillemin G (2000) Experimental vertebroplasty using osteoconductive granular material. Spine 25: 1070-1076.
13. Dawes KE, Gray AJ, Laurent GJ (1993) Thrombin stimulates fibroblast chemotaxis and replication. Eur J Cell Biol 61: 126-130.
14. De Bari C, Dell'Accio F, Vanlauwe J, Eyckmans J, Khan IM, Archer CW, Jones EA, McGonagle D, Mitsiadis TA, Pitzalis C, Luyten FP (2006) Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum 54: 1209-1221.
15. Dunn CJ, Goa KL (1999) Tranexamic acid: a review of its use in surgery and other indications. Drugs 57: 1005-1032.
16. Eniwumide JO, Lee DA, Bader DL (2009) The development of a bioreactor to perfuse radially-confined hydrogel constructs: design and characterization of mass transport properties. Biorheology 46: 417-437.
17. Eyckmans J, Luyten FP (2006) Species specificity of ectopic bone formation using periosteum-derived mesenchymal progenitor cells. Tissue Eng 12: 2203-2213.
18. Eyckmans J, Roberts SJ, Schrooten J, Luyten FP (2010) A clinically relevant model of osteoinduction: a process requiring calcium phosphate and BMP/Wnt signalling. J Cell Mol Med 14: 1845-1856.
19. Eyrich D, Brandl F, Appel B, Wiese H, Maier G, Wenzel M, Staudenmaier R, Goepferich A, Blunk T (2007) Long-term stable fibrin gels for cartilage engineering. Biomaterials 28: 55-65.
20. Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV (1966) Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 16: 381-390.
21. Frost A, Jonsson KB, Ridefelt P, Nilsson O, Ljunghall S, Ljunggren O (1999) Thrombin, but not bradykinin, stimulates proliferation in isolated human osteoblasts, via a mechanism not dependent on endogenous prostaglandin formation. Acta Orthop Scand 70: 497-503.
22. Gorodetsky R, Vexler A, An J, Mou X, Marx G (1998) Haptotactic and growth stimulatory effects of fibrin(ogen) and thrombin on cultured fibroblasts. J Lab Clin Med 131: 269-280.
23. Gray AJ, Bishop JE, Reeves JT, Laurent GJ (1993) A alpha and B beta chains of fibrinogen stimulate proliferation of human fibroblasts. J Cell Sci 104: 409-413.
24. Hardy JF, Desroches J (1992) Natural and synthetic antifibrinolytics in cardiac surgery. Can J Anaesth 39: 353-365.
25. Huang CY, Deitzer MA, Cheung HS (2007) Effects of fibrinolytic inhibitors on chondrogenesis of bone-marrow derived mesenchymal stem cells in fibrin gels. Biomech Model Mechanobiol 6: 5-11.
26. Isogai N, Landis WJ, Mori R, Gotoh Y, Gerstenfeld LC, Upton J, Vacanti JP (2000) Experimental use of fibrin glue to induce site-directed osteogenesis from cultured periosteal cells. Plast Reconstr Surg 105: 953-963.
27. Jackson MR (2001) Fibrin sealants in surgical practice: An overview. Am J Surg 182: 1S-7S.
28. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP (1997) Osteogenic differentiation of purified, cultureexpanded human mesenchymal stem cells in vitro. J Cell Biochem 64: 295-312.
29. Jarzem P, Harvey EJ, Shenker R, Hajipavlou A (1996) The effect of fibrin sealant on spinal fusions using allograft in dogs. Spine 21: 1307-1312.
30. Jung S, Sen A, Rosenberg L, Behie LA (2010) Identification of growth and attachment factors for the serum-free isolation and expansion of human mesenchymal stromal cells. Cytotherapy 12: 637-657.
31. Kalia P, Coathup MJ, Oussedik S, Konan S, Dodd M, Haddad FS, Blunn GW (2009) Augmentation of bone growth onto the acetabular cup surface using bone marrow stromal cells in total hip replacement surgery. Tissue Eng Part A 15: 3689-3696.
32. Kania RE, Meunier A, Hamadouche M, Sedel L, Petite H (1998) Addition of fibrin sealant to ceramic promotes bone repair: long-term study in rabbit femoral defect model. J Biomed Mater Res 43: 38-45.
33. Kupcsik L, Alini M, Stoddart MJ (2009) Epsilonaminocaproic acid is a useful fibrin degradation inhibitor for cartilage tissue engineering. Tissue Eng Part A 15: 2309-2313.
34. Lee CR, Grad S, Gorna K, Gogolewski S, Goessl A, Alini M (2005) Fibrin-polyurethane composites for articular cartilage tissue engineering: a preliminary analysis. Tissue Eng 11: 1562-1573.
35. LeGuehennec L, Layrolle P, Daculsi G (2004) A review of bioceramics and fibrin sealant. Eur Cell Mater 8: 1-11.
36. Martin I, Muraglia A, Campanile G, Cancedda R, Quarto R (1997) Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 138: 4456-4462.
37. McGee-Russell SM (1958) Histochemical methods for calcium. J Histochem Cytochem 6: 22-42.
38. Meinhart J, Fussenegger M, Hobling W (1999) Stabilization of fibrin-chondrocyte constructs for cartilage reconstruction. Ann Plast Surg 42: 673-678.
39. Mosesson MW, Siebenlist KR, Meh DA (2001) The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci 936: 11-30.
40. Murkin JM (2009) Lessons learned in antifibrinolytic therapy: The BART trial. Semin Cardiothorac Vasc Anesth 13: 127-131.
41. Nakahara H, Bruder SP, Haynesworth SE, Holecek JJ, Baber MA, Goldberg VM, Caplan AI (1990) Bone and cartilage formation in diffusion chambers by subcultured cells derived from the periosteum. Bone 11: 181-188.
42. Ng AM, Saim AB, Tan K, Tan GH, Mokhtar SA, Rose IM, Othman F, Idrus RBH (2005) Comparison of bioengineered human bone construct from four sources of osteogenic cells. J Orthop Sci 10: 192-199.
43. Noailly J, Van OH, Wilson W, Quinn TM, Ito K (2008) A poroviscoelastic description of fibrin gels. J Biomech 41: 3265-3269.
44. Perka C, Schultz O, Spitzer RS, Lindenhayn K, Burmester GR, Sittinger M (2000) Segmental bone repair by tissue-engineered periosteal cell transplants with bioresorbable fleece and fibrin scaffolds in rabbits. Biomaterials 21: 1145-1153.
45. Radisic M, Malda J, Epping E, Geng W, Langer R, Vunjak-Novakovic G (2006) Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng 93: 332-343.
46. Solchaga LA, Penick K, Porter JD, Goldberg VM, Caplan AI, Welter JF (2005) FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrowderived mesenchymal stem cells. J Cell Physiol 203: 398-409.
47. Tholpady SS, Schlosser R, Spotnitz W, Ogle RC, Lindsey WH (1999) Repair of an osseous facial criticalsize defect using augmented fibrin sealant. Laryngoscope 109: 1585-1588.
48. Tsutsumi S, Shimazu A, Miyazaki K, Pan H, Koike C, Yoshida E, Takagishi K, Kato Y (2001) Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 288: 413-419.
49. Volkmer E, Drosse I, Otto S, Stangelmayer A, Stengele M, Kallukalam BC, Mutschler W, Schieker M (2008) Hypoxia in static and dynamic 3D culture systems for tissue engineering of bone. Tissue Eng Part A 14: 1331-1340.
50. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228.
51. Colnot C (2009) Skeletal fate decisions within periosteum and bone marrow during bone regeneration. J Bone Miner Res 24: 274-282.
52. Solchaga LA, Cassiède P, Caplan AI (1998) Different response to osteo-inductive agents in bone marrow and periosteum-derived cell preparations. Acta Orthop Scand 69: 426-432.